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Summary. The expression levels of seven different S100 
proteins (S100A1, S100A2, S100A3, S100A4, S100A5, 
S100A6, and S100B) were characterized by 
immunohistochemistry in the epithelial versus 
connective tissues of a series of 35 colon specimens, 
including 6 normal samples, 5 adenomas with low-grade 
dysplasia, 5 adenomas with high-grade dysplasia, and 19 
cancers. The results showed that S100A2, S100A3, and 
SlOOB proteins could not (or only marginally) be 
detected in colon tissues. On the other hand, the 
expression of S100A6 increased in epithelial tissues 
directly proportional to the increase of malignancy. The 
percentage of epithelial (or connective tissue) cells 
expressing S100A4 significantly decreased as the 
malignancy grade increased. The expression level of 
SlOOAl proteins was somewhat higher in the connective 
tissues of normal cases and adenomas with low-grade 
dysplasia than in adenomas with high-grade dysplasia 
and cancers. This pattern of expression was not observed 
in epithelial tissues. While the node-positive cancers did 
not express S100A1, about half of the node-negative 
specimens did. The expression levels of S100A5 were 
similar in different epithelial tissues. However, in the 
connective tissues the expression levels decreased 
inversely proportional to the increase in pathological 
grading of the specimens. Therefore, the present study 
implicates several S100 proteins as useful tools for 
histochemical typing of colon cancer malignancy 
development. 
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lntroduction 
The S100 proteins belong to the superfamily of 
proteins containing the EF-hand ca2+-binding motif 
(Nakayama and Kretsinger, 1994; Schafer and 
Heizmann, 1996; Heizmann and Cox, 1998). In contrast 
to calmodulin, which is ubiquitously expressed, S100 
proteins are found in specific cell types such as nerve, 
glial, or epithelial cells. Recently, a large subset of new 
S100 proteins was identified, and a cluster of 13 genes 
encoding S100 proteins was identified on human 
chromosome lq21 (Schafer et al., 1995; Schafer and 
Heizmann, 1996; .Wicki et al., 1996a,b; Heizmann and 
Cox, 1998), which is evolutionarily conserved on mouse 
chromosome 3 (Ridinger et al., 1998). Involvement of 
S100 proteins in biological functions such as cell 
proliferation, apoptosis, motility, exocytosis or 
cytoskeletal organization has already been demonstrated 
(Schafer and Heizmann, 1996; Heizmann and Cox, 
1998). Although their role in cancer pathogenesis still 
remains to be elucidated, recent reports consistently 
show that specific S100 proteins, especially S100A4, 
modify the biological behavior of severa1 tumor cells 
(Grigorian et al., 1996; Lloyd et al., 1998). Furthermore, 
Keirsebilck et al. (1998) reported that S100A4 is 
inversely regulated with respect to E-cadherin, which is 
an invasion suppressor molecule. In addition, S100A2 is 
a possible candidate for tumor suppression in breast 
cancer (Wicki et al., 1997). Moreover, we demonstrated 
that the expression levels of severa1 S100 proteins 
(S 100A3, S100A4, S100A6, S100B) significantly varied 
with respect to the increasing level of malignancy in 
brain tumors deriving from the astroglial lineage, while 
S100A2 was never expressed in such tumors (Camby et 
al., 1999). Severa1 studies already report the differential 
expression of S100A4 and S100A6 proteins in colon 
tissues, in relation to malignancy development 
(Takenaga et al., 1997; Komatsu et al., 2000; Stulik et 
S 1 O0 protein expression in normal and tumoral colon 
al., 2000). In addition, others report different expression 
levels of SlOOB in the neme cells of colon tissues under 
various pathological conditions (inflammatory bowel 
disease, ulcerative colitis, acute appendicitis, etc) 
(Kubota et al., 1992; Waraich et al., 1997; Monforte- 
Munoz et al., 1998). However, none study compared the 
leve1 of expression of severa1 S100 proteins in colon 
tissues, whether these tissues are normal, dysplastic or 
malignant. The present work thus characterizes the 
differential expression levels of 7 different S100 proteins 
in a series of 35  human colon specimens (including 
normal cases, adenomas with low- versus high-grade 
dysplasia, and cancers), demonstrating correlation 
between S100 protein expression and different stages of 
neoplasia. 
Materlals and methods 
Specimens 
The series of 35 colon tissue specimens consisted of 
6 normal, 10  adenoma, and 1 9  cancer samples. The 
normal specimens came from routine biopsies taken 
from normal colorectal areas of patients subjected to 
coloscopy. 
Dysplasia grading was carried out as  recently 
detailed (Bronckart et al., 1999). Ail the gradings were 
performed by three pathologists simultaneously 
reviewing each case through a multihead microscope. 
The adenomas were graded (low versus high-grade 
dysplasia) in relation to the most advanced focus of 
dysplasia observed. A consensus classification of each 
case was obtained by means of the criteria that we have 
described previously (Bronckart et al., 1999). 
Cancer staging was carried out according to the 
TNM system (Beahrs et al., 1992). The 1 9  cancer 
specimens included 4 TI,  5 T2 ,5  T3, and 5 T4 cases. Of 
the 19 samples, 8 exhibited node invasions. None of the 
8 node-positive colon cancers exhibited dista1 
metastases. Al1 of the 1 9  cancer cases were M0 
according to the TNM staging system. 
lmmunohistochemical staining 
The tissue specimens were fixed in 4% buffered 
formaldehyde and embedded in paraffin. Five-pm 
sections from each specimen were stained with the 
various antibodies against S100 proteins at 25 2 1 "C for 
60 minutes (Camby et al., 1999). The following dilutions 
were used: SlOOAl - 1:2000, S100A2 - 1500, S100A3 - 
1:2000, S100A4 - 1:2000, S100A5 - 1500,  S100A6 - 
1:10000, and SlOOB - 1:10000. Visualization of 
immunoreactive protein was achieved with the avidin- 
biotin-peroxidase complex (ABC) kit reagents (Vector 
Labs, Burlingame, CA), with diaminobenzidineM202 as 
the chromogenic substrates. The control tissues were 
incubated with the corresponding pre-immune sera, the 
second antibody only, or with polyclonal antibodies 
against S100 proteins preabsorbed with the 
corresponding antigens. Counterstaining was done with 
toluidine blue. 
Antibodies against human recombinant S100A2, 
S100A3, and SlOOB were raised in rabbits, and 
antibodies against human recombinant S100A1, 
S100A4, and S100A6 were raised in goats (Fohr et al., 
1995; Huang et al., 1996; Ilg et al., 1996). 
Evaluation of immunohistochemical staining 
The analysis was carried out according to the 
methodology adapted from Gama110 et al. (1993), 
showing a correlation between levels of expression and 
histological tumor typing. We estimated the staining 
intensity of each S100 protein (Staining Intensity {SI) 
variable) and the abundance of S100 protein 
immunoreactive cells (Labeling Index {LI) variable) 
both in the epithelial and the connective tissues. The LI 
variable was graded from O to 2 by counting the 
percentage of positive cells (for epithelial tissue) or of 
positive areas (for connective tissue) in at least 20 fields 
(x400) per specimen. The LI scores were O in the 
absence of staining, 1 when 1-30% of cells or tissue area 
were reactive, and 2 when more than 30% of cells or 
tissue area were reactive. The SI variable was graded O 
in the absence of staining (or staining equivalent to 
background staining in the negative control), 1 where 
staining was weak to moderate, and 2 where staining 
was intense. The final LI/SI score for a given colon 
specimen corresponded to the most frequent of the 20 
LI/SI scores assessed for each specimen. 
The scores were examined independently by two 
investigators.  In case of disagreement, a third 
investigator examined the scores. 
Statistical analyses 
The four histopathological groups were labeled as 
follows: normal = 0, low-grade dysplasia = 1, high-grade 
dysplasia = 2, and neoplastic = 3. Cancer stages were 
given a score of 1 for low stages (TI and T2) and a score 
of 2 for high stages (T3 and T4); similarly, node- 
negative cancers were given a score of 1 and node- 
positive cancers a score of 2. The Chi-square (for 
comparing 2 groups) and the Kendall tests (for 
comparing more than two groups) were used to evaluate 
the statistical correlations between the histopathological 
variables and individual S100 protein expression 
(estimation for epithelial and connective tissues was 
performed using both the LI and SI variables). Ail the 
statistical analyses were carried out using Statistica 
(Statsoft, Tulsa, OK, USA). 
Results 
Morphological illustrations of S 100 protein expression 
We analyzed colon tissue specimens for expression 
of different S100 proteins. Figure 1 illustrates the 
S1 O0 protein expression in normal and tumoral colon 
S100A5 expression observed in normal (A), high-grade 
dysplastic (B) and neoplastic (C) human colon tissue, 
and similarly for S100A6 (D-F). This figure shows 
variations in S100A5 expression in connective tissue and 
those in S100A6 expression in epithelial tissue. 
Correlation of S100 protein expression with different 
grades of neoplasia 
We correlated differential expression of S100 
proteins with increasing levels of neoplasia, a s  
summarized in Table 1. S100A2, S100A3, and SlOOB 
proteins were barely (or not) detectable in colon 
specimens. In contrast, expression levels of S100A5 and 
S100A6 varied considerably among the 
histopathological groups of human colon specimens (as 
illustrated in Fig. 1). The expression level of S100A5 
protein in connective tissue significantly decreased (both 
for the LI and S I  variables) from normal through 
adenomas with low-grade dysplasia, adenomas with 
high-grade dysplasia, to cancers (Table l ) ,  while no 
significant variations appeared in epithelial tissue. The 
reverse phenomenon was observed for S100A6 protein 
in epithelial tissue (but not in connective tissue), with a 
marked increase of expression directly proportional to 
the increase in the level of morphoiogical abnormality 
(Table 1). However, there was no further increase in 
expression level of S100A6 (in epithelial tissue) from 
adenomas with high-grade dysplasia to cancers. The 
percentage of S100A4-positive connective tissue area 
significantly decreased a s  the malignancy level 
increased, while S100A4 staining intensity did not 
change in relation to the histopathological diagnosis 
(Table 1). Lastly, the percentage of S100A1-positive 
cells in connective tissue @ut not in epithelial cells) was 
significantly -higher in normal cases and in adenomas 
with low-grade dysplasia than in adenomas with high- 
grade dysplasia and in cancers, while staining intensity 
remained similar (Table 1). 
Correlation of S100 protein expression with tumor 
prognosis 
With respect to prognostic variables (stage, node- 
negative versus node-positive cancers), only SlOOAl 
expression exhibited significant changes. Indeed, the 
proportion of S100A1-positive samples was 6/11 in the 
node-negative group versus 018 in the node-positive 
group (P = 0.01). Such variance in SlOOAl expression 
occurred only in epithelial tissue. 
Flg. 1. Illustration of the variation in S100A5 staining in connecüve tissue between normal (A), high-grade dysplasia (B) and neoplastic (C) human 
colon tissue (x 200). lllustration of the variation in S100A6 staining in epithelial tissue between normal (D), high-grade dysplasia (E) and neoplastic (F) 
human colon tissue (x 200). 
S1 O0 protein expression in normal and tumoral colon 
Table 1. Correlations between SI00 protein expression and histopathological diagnoses. Proportions of positive cases for each SI00 protein. 
HISTOPATHOLOGICAL TISSUE S1 OOAl SIOOA2 SlOOA3 S100A4 S100A5 S100A6 S I  OOB 
DIAGNOSES TYPE 
normal 
(n = 6) 
low-grade dysplasia 
(n = 5) 
high-grade dysplasia 
(n = 5) 
cancer 
(n = 19) 
connective 
epithelial 
connective 
epithelial 
connective 
epithelial 
connective 
epithelial 
P level of statistical connective: LI variable - 0.006 n.s. n.s. - 0.003 - 0.000001 n.s. n.s. 
significance connective: SI variable n.s. n.s. n.s. n.s. - 0.000001 n.s. n.s. 
(n.s. = not significant epithelial: LI variable n.s. n.s. n.s. + 0.009 n.s. + 0.00006 n.s. 
{P > 0.05}) epithelial: SI variable n.s. n.s. n.s. n.s. n.s. + 0.00004 n.s. 
n: nurnber of cases. For each S100 protein the semi-quantitative evaluation of the immunohistochemical staining was made in epithelial and connective 
tissues by means of two variables: the staining intensity (the SI variable) and the relative abundance of SI00 protein immunoreactive cells (Labeling 
lndex or LI variable). The SI variable was graded as O (equivalent to background staining in the negative control slide), 1 (weak to rnoderate staining) or 
2 (intense staining). The LI variable was graded as O = no staining, 1 = between 1 and 30% of immunostained cells or tissue area, 2 = more than 30% 
of immunostained cells or tissue area. Positive cases induded al1 cases with an LIISI phenotype difíerent from 010. The Kendall test was used to 
evaluate the statistical correlations between LI (or SI) scores and the histological grade (normal = 0, low-grade dysplasia = 1, high-grade dysplasia = 2, 
cancer = 3). The sign "-" associated with a given P value indicates a negative correlation, while the sign "+" indicates a positive correlation. 
Discussion 
Histologically, adenomas are defined as benign 
neoplasms of gland-forming epithelia. High-grade 
dysplasia features in adenomas are considered to be 
immediate precursors of colorectal carcinomas. 
Considering pathogenesis of colon carcinomas as a 
development of pre-existing adenomas (Bronckart et al., 
1999), high-grade dysplasia may be the link between 
benign adenomas and invasive cancers (Sugarbaker et 
al., 1985; Steele et al., 1993). Recently, Allen (1995) 
reviewed al1 known molecular events occurring in the 
transformation of a normal colon mucosa into a 
neoplastic one, emphasizing the histological standpoint 
reported above. The molecular abnormalities underlying 
this progression include early dysfunction in the 
adenomatous polyposis coli (APC) gene (Allen, 1995). 
The aims of the present study were to investigate: i) 
whether progression towards increasing levels of 
neoplasia was associated with an altered expression of 
distinct S100 proteins; and ii) if expression of specific 
S100 proteins might have prognostic significance. 
We chose the S100 family of proteins because of 
their already described association with tumor 
progression and their interactions with the p53 tumor 
suppressor gene (Baudier et al., 1992; Tan et al., 1999). 
Some S100 proteins regulate motility of normal cells 
and the cytoskeleton, particularly by altering the 
invasiveness of tumor cells (Selinfreud et al., 1990, 
1991; Grigorian et al., 1996; Wicki et  al., 1997;  
Keirsebilck et al., 1998; Lloyd et al., 1998; Mandinova 
et al., 1998; Camby et al., 1999). 
Baudier et al. (1992) reported that p53 may be a 
cellular target for the members of the S100 protein 
family involved in the control of the cell cycle at the GO- 
Gl/S boundary. The SlOOAl and SlOOB proteins can 
interact with the p53 tumor suppressor gene (Baudier et 
al., 1992), which plays a significant role in the 
development of malignancy in colon tumors (Allen, 
1995). The SlOOB protein interacts in a calcium- 
dependent manner with the p53 protein, and this 
interaction inhibits p53 protein phosphorylation by 
protein kinase C in vitro (Baudier et al., 1992). It was 
also shown (Tan et al., 1999) that p53 positively 
regulates S100A2 expression. SlOOB was also found to 
activate Ndr, a nuclear protein kinase known to be 
involved in cell division and cell morphology (Milward 
et al., 1998). 
The data obtained in the present study demonstrate 
that of the seven S100 proteins tested, the expression 
levels of S100A5 and S100A6 varied considerably 
relative to the histopathological grades of the tissues; in 
particular, the expression levels of S100A5 in connective 
tissues and S100A6 in epithelial tissues (see Table 1). In 
fact, both staining intensity and percentage of positive 
tissue areas for S100A5 markedly decreased in the 
connective tissues inversely proportional to the increase 
in histopathological grades, while the reverse correlation 
was observed for S100A6 in epithelial tissues. This is in 
agreement with a notion that S100A6 i s  involved in cell 
proliferation (Calabretta et al., 1986) and exocytosis 
(Okazaki et al., 1994). Our S100A6-related results also 
perfectly match those recently reported by Komatsu et 
al. (2000) which show (by means of western blot and 
immunohistochemical analyses) high expression levels 
of S100A6 in epithelial tissue of adenocarcinomas in 
comparison to normal mucosa and, to a lesser extent, to 
adenomas. To date, the physiological role of S100A5 has 
S 1 O0 protein expression in normal and tumoral colon 
not yet been identified. It is therefore not possible to 
determine the putative molecular mechanisms 
underlying the decrease of S100A5 expression in 
relation to the increase of malignancy. The possibility 
remains that the high leve1 of S100A5 expression in the 
connective tissue of both normal and weakly dysplastic 
colon tissue reflects the accumulation of S100A5 
secreted by epithelial cells,  while this secretion 
decreases as  these epithelial cells become highly 
dysplastic or malignant. It should be also emphasize that 
we were not able to perform a distinction between 
tumor-associated connective tissue and regular (non- 
tumor) mesenchyme. 
Two other S100 proteins (S100A1 and S100A4) 
showed modified expression in relation to the 
histopathological grades. A negative correlation was 
obtained with the LI variable evaluated in connective 
tissue for both SlOOAl and S100A4, and a positive 
correlation in epithelial tissue for S100A4 only (see 
Table 1). S100A2, S100A3, and SlOOB immunohisto- 
chemistry yielded no diagnostic information. 
Expression of SlOOAl in node-negative cancer and 
its lack in node-positive cancers suggests that loss of 
SlOOAl could play a role in the early steps of colon 
cancer invasion. No significant difference in the 
expression of the remaining six S100 proteins was 
observed between stages T1 and T2, or T3  and T4. 
In conclusion, the present study suggests that several 
members of the S100 family of proteins, such as  
S100A1, S100A4, S100A5, and S100A6, might be 
involved in the development and progression of 
malignancy in human colon tissues. While S100A4, 
S100A5, and S100A6 appear to be important for the 
development of malignancy, SlOOAl may be a regulator 
during tumor progression. We are now in the process of 
investigating the possible roles of S100 proteins on cell 
kinetics and cell motility in tumor cells by means of a 
video cell tracking system recently developed in our 
laboratory (De Hauwer et al., 1997, 1998). 
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